Overview
Teresa Slomka is a Cardiologist in Warwick, Rhode Island. Dr. Slomka is rated as an Advanced provider by MediFind in the treatment of Heart Attack. Her top areas of expertise are Heart Attack, Atrial Fibrillation, Apoplexy, and Atherosclerosis.
Her clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
455 Toll Gate Rd, Warwick, RI 02886
75 Francis St, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Tufts Medical Center Cardiology
Navin Kapur is a Cardiologist in Boston, Massachusetts. Dr. Kapur is rated as an Elite provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Cardiogenic Shock, Heart Attack, Heart Failure, Heart Transplant, and Percutaneous Coronary Intervention (PCI).
Brigham And Women's Hospital
David Morrow is a Cardiologist in Boston,, Massachusetts. Dr. Morrow is rated as an Elite provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Cardiogenic Shock, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Thrombectomy.
Beth Israel Deaconess Medical Center
Robert Yeh is a Cardiologist in Boston,, Massachusetts. Dr. Yeh is rated as an Elite provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Heart Attack, Coronary Heart Disease, Angina, Percutaneous Coronary Intervention (PCI), and Stent Placement.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adenosine Deaminase 2 DeficiencyDr. Slomka isAdvanced. Learn about Adenosine Deaminase 2 Deficiency.
- AnginaDr. Slomka isAdvanced. Learn about Angina.
- ApoplexyDr. Slomka isAdvanced. Learn about Apoplexy.
- ArrhythmiasDr. Slomka isAdvanced. Learn about Arrhythmias.
- Arterial EmbolismDr. Slomka isAdvanced. Learn about Arterial Embolism.
- AtherosclerosisDr. Slomka isAdvanced. Learn about Atherosclerosis.
- Experienced
- Acute Coronary SyndromeDr. Slomka isExperienced. Learn about Acute Coronary Syndrome.
- Aortic RegurgitationDr. Slomka isExperienced. Learn about Aortic Regurgitation.
- Aortic Valve StenosisDr. Slomka isExperienced. Learn about Aortic Valve Stenosis.
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Arterial InsufficiencyDr. Slomka isExperienced. Learn about Arterial Insufficiency.
- Atrial MyxomaDr. Slomka isExperienced. Learn about Atrial Myxoma.